We are live on ! Find out more
TRHC

Tabula Rasa HealthCare, Inc. Common Stock

Delisted

TRHC was delisted on the 2nd of November, 2023.

127 hedge funds and large institutions have $497M invested in Tabula Rasa HealthCare, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

840% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

85% more capital invested

Capital invested by funds: $268M → $497M (+$229M)

49% more funds holding

Funds holding: 85127 (+42)

34% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 29

Holders
127
Holders Change
+42
Holders Change %
+49.41%
% of All Funds
2.91%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
47
Increased
39
Reduced
29
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$3.88M +$2.61M +74,614 +293%
SPPAM
27
Summit Partners Public Asset Management
Massachusetts
$3.88M -$2.1M -60,000 -38%
Principal Financial Group
28
Principal Financial Group
Iowa
$3.87M +$3.49M +99,731 New
IECM
29
Intrinsic Edge Capital Management
Illinois
$3.69M +$3.33M +95,000 New
JP Morgan Chase
30
JP Morgan Chase
New York
$3.64M +$1.1M +31,353 +50%
NCGI
31
Next Century Growth Investors
Minnesota
$3.37M -$102K -2,914 -3%
OCM
32
Osterweis Capital Management
California
$3.2M +$2.89M +82,425 New
PCMI
33
Paradigm Capital Management Inc
New York
$3.12M -$70.1K -2,000 -2%
DA
34
DSC Advisors
Illinois
$3.1M
AQR Capital Management
35
AQR Capital Management
Connecticut
$3.03M +$2.74M +78,108 New
TCM
36
Tygh Capital Management
Oregon
$2.73M +$2.47M +70,347 New
BG
37
Bellevue Group
Switzerland
$2.25M
Deutsche Bank
38
Deutsche Bank
Germany
$2.23M +$1.26M +36,086 +169%
BAMCO Inc
39
BAMCO Inc
New York
$2.13M +$1.93M +55,000 New
BG
40
Bollard Group
Massachusetts
$2.13M +$1.92M +54,925 New
RA
41
Royce & Associates
New York
$1.94M
Morgan Stanley
42
Morgan Stanley
New York
$1.9M +$703K +20,062 +69%
FA
43
Friess Associates
Delaware
$1.9M -$8.62M -246,102 -83%
LCG
44
Lisanti Capital Growth
New York
$1.84M +$798K +22,760 +92%
CCM
45
Cadence Capital Management
Massachusetts
$1.79M +$861K +24,569 +113%
Renaissance Technologies
46
Renaissance Technologies
New York
$1.7M -$1.5M -42,800 -49%
William Blair & Company
47
William Blair & Company
Illinois
$1.7M +$863K +24,625 +128%
Invesco
48
Invesco
Georgia
$1.66M -$1.38M -39,260 -48%
EGI
49
EAM Global Investors
California
$1.59M
FG
50
Formula Growth
Quebec, Canada
$1.55M

TRHC Hedge Fund Activity: Q1 2018 in Review

127 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Tabula Rasa HealthCare, Inc. Common Stock (TRHC) for Q1 2018, worth a combined $497M — up 85% from $268M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new TRHC positions and 5 closed out — a net gain of 42 holders — while 39 added to existing stakes and 29 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $49.1M. The largest seller was Marshall Wace North America, cutting an estimated $13.1M.

  • 127 institutional investors held Tabula Rasa HealthCare, Inc. Common Stock (TRHC) as of Q1 2018, up from 85 in Q4 2017.
  • Funds reported $497M of Tabula Rasa HealthCare, Inc. Common Stock stock for Q1 2018, up 85% quarter-over-quarter.
  • 47 funds opened new Tabula Rasa HealthCare, Inc. Common Stock positions in Q1 2018 and 5 closed out, a net change of +42 holders.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock buyer in Q1 2018 was Capital Research Global Investors, an estimated $49.1M added.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock seller in Q1 2018 was Marshall Wace North America, an estimated $13.1M sold.

Based on aggregated 13F filings for Q1 2018.